Cite
MLA Citation
Claire Bonneau et al.. “Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.” European journal of cancer, vol. 95, 2018, pp. 75–84. http://access.bl.uk/ark:/81055/vdc_100060348475.0x000020